Inaugurates a lab in the IISc premise to enable students in their academic research
Funds 2 Master students through a CSR-sponsored MTech fellowship program
Bengaluru, NFAPost: ZEISS in India has announced its strategic collaboration with the Indian Institute of Science (IISc), Bangalore, to foster cutting edge research. ZEISS has established a sophisticated state-of-the-art research facility dedicated for developing high fidelity Artificial Intelligence (AI) solutions for the betterment of eye-care and to upskill students in AI technologies.
The initiative, supported by the Spectrum Lab in the Department of Electrical Engineering at IISc, aims to harness the transformative potential of AI to enhance eye-care practices and improve patient outcomes.
This collaboration will propel improvements in eye care solutions from India for the world considering the rising prevalence of vision impairments worldwide. The facility will act as a center for cutting-edge research, allowing IISc researchers to investigate how AI could transform early diagnosis in eye care by providing innovative solutions that streamline processes, increase accuracy, and improve patient outcomes. ZEISS India and IISc have joined forces to explore and promote the use of advanced AI technologies in ophthalmology.
ZEISS India Head of the Centre for Application Research India (CARIn) Ashish Modi said the company believes that meaningful innovation emerges at the intersection of academia and industry.
“Our collaboration with IISc is a step towards bridging this gap, empowering Indian researchers with advanced resources and real-world applications. By fostering a sustainable research ecosystem, we aim to drive global breakthroughs in eye-care technology while strengthening India’s position as a hub for scientific excellence. Long-term industry-academia partnerships are essential to accelerating innovation and making cutting-edge healthcare solutions more accessible,” said ZEISS India Head of the Centre for Application Research India (CARIn) Ashish Modi.
IISc Dean of Division (Electrical Electronics, and Computer Sciences Division) Rajesh Sundaresan said this collaboration is a significant step toward empowering Indian researchers and advancing global eye-care innovation.
“Partnerships like these demonstrate how private players can accelerate innovation by leveraging academic expertise, leading to breakthrough technologies with real-world impact. Long-term collaborations between industry and academia are essential for fostering a sustainable research ecosystem in India. They provide young researchers with the resources and exposure needed to drive scientific advancements while addressing real-world challenges,” said IISc Dean of Division (Electrical Electronics, and Computer Sciences Division) Rajesh Sundaresan.
He also pointed out that India needs more such partnerships to remain at the forefront of technological progress, ensuring that innovation is developed and applied to improve lives globally.”
In addition to the lab set-up, ZEISS India is also sponsoring 6 MTech students for the next 3 years through its CSR-sponsored ‘MTech Fellowship Program‘ at IISc for students pursuing master’s degree in Signal Processing, Artificial Intelligence, Computer Science & Engineering/Computational and Data Science.
Together with IISc, ZEISS intends to build a strong engagement that serves as a linchpin in promoting the adoption of AI in eye care. The effort can demystify AI technologies and cultivate trust amongst patients and the broader community through public demonstrations, exhibitions, and patient testimonials. Emphasizing the cost-effectiveness and accessibility of AI-driven eye care solutions further reinforces its appeal and relevance in diverse healthcare settings.
About ZEISS Group:
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 10.9 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets.
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world’s leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company’s significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS’ technology and market leadership. ZEISS invests 15 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.
With around 46,485 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 30 September 2023). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Leave a Reply